Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the src SH2 domain binding

被引:55
作者
Nam, NH
Ye, GF
Sun, GQ
Parang, K [1 ]
机构
[1] Univ Rhode Isl, Dept Biomed Sci, Kingston, RI 02881 USA
[2] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA
关键词
D O I
10.1021/jm040008+
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of conformationally constrained peptides were designed and synthesized as the Src SH2 domain ligands based on a tetrapeptide sequence pTyr-Glu-Glu-Ile (pYEEI). In general, the constrained peptides such as compounds 6, 7, and 11 (IC50 = 1.1-1.5 muM) showed higher binding affinities to the Src SH2 domain relative to the corresponding linear peptides 8a, 9a, and 13a, respectively (IC50 > 100 muM), and pYEEI (IC50 = 6.5 muM), as evaluated by a fluorescence polarization assay. Molecular modeling studies revealed that in constrained peptides, the isoleucine side chain penetrates very deeply into the hydrophobic binding pocket (P + 3 site) of the Src SH2 domain. These constrained peptides can serve as novel templates for the design of small and nonpeptidic inhibitors of the Src SH2 domain.
引用
收藏
页码:3131 / 3141
页数:11
相关论文
共 36 条
[1]   Preparation of succinimidyl and pentafluorophenyl active esters of 5- and 6-carboxyfluorescein [J].
Adamczyk, M ;
Fishpaugh, JR ;
Heuser, KJ .
BIOCONJUGATE CHEMISTRY, 1997, 8 (02) :253-255
[2]   SEQUENCE REQUIREMENTS FOR BINDING OF SRC FAMILY TYROSINE KINASES TO ACTIVATED GROWTH-FACTOR RECEPTORS [J].
ALONSO, G ;
KOEGL, M ;
MAZURENKO, N ;
COURTNEIDGE, SA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (17) :9840-9848
[3]   REQUIREMENT OF PP60C-SRC EXPRESSION FOR OSTEOCLASTS TO FORM RUFFLED BORDERS AND RESORB BONE IN MICE [J].
BOYCE, BF ;
YONEDA, T ;
LOWE, C ;
SORIANO, P ;
MUNDY, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1622-1627
[4]   Structure-based design and synthesis of a novel class of Src SH2 inhibitors [J].
Buchanan, JL ;
Bohacek, RS ;
Luke, GP ;
Hatada, M ;
Lu, XD ;
Dalgarno, DC ;
Narula, SS ;
Yuan, R ;
Holt, DA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (16) :2353-2358
[5]   Structure-activity relationships of a novel class of Src SH2 inhibitors [J].
Buchanan, JL ;
Vu, CB ;
Merry, TJ ;
Corpuz, EG ;
Pradeepan, SG ;
Mani, UN ;
Yang, M ;
Plake, HR ;
Varkhedkar, VM ;
Lynch, BA ;
MacNeil, IA ;
Loiacono, KA ;
Tiong, CL ;
Holt, DA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (16) :2359-2364
[6]   Phosphotyrosyl mimetics in the development of signal transduction inhibitors [J].
Burke, TR ;
Lee, K .
ACCOUNTS OF CHEMICAL RESEARCH, 2003, 36 (06) :426-433
[7]  
Burke TR, 2001, BIOPOLYMERS, V60, P32, DOI 10.1002/1097-0282(2001)60:1<32::AID-BIP1002>3.0.CO
[8]  
2-I
[9]   Calorimetric and structural studies of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide inhibitors of Src SH2 domain binding [J].
Davidson, JP ;
Lubman, O ;
Rose, T ;
Waksman, G ;
Martin, SF .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (02) :205-215
[10]   Discovery of highly potent Src SH2 binders:: Structure-activity studies and X-ray structures [J].
Deprez, P ;
Baholet, I ;
Burlet, S ;
Lange, G ;
Amengual, R ;
Schoot, B ;
Vermond, A ;
Mandine, E ;
Lesuisse, D .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (09) :1291-1294